RNSTRENASANT CORP
State Commercial Banks
- Revenue
- —
- Operating margin
- —
- EBITDA
- —
- Market cap
- $3.6B
- Employees
- 3,000
- Net debt / EBITDA
- —
- −$85M net debt
- AI in 10-K
- 2.5
- mentions per 10K words
Takeover score 1 of 13
Fixable underperformance 0 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo150% of net incomeCash flow under 80% of net income
- Dilutive SBCNo—Over 10% of revenue
- Payouts exceed cash flowNo34% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo5% of assetsOver 40% of assets
- Shareholder dissentNo84% lowest supportAny vote under 80% support
Buyer economics 1 of 4
- Low revenue per employeeNo—Bottom quartile of its SIC industry
- Quiet on AINo2.5 per 10K words · 63rd pctBottom quartile of AI mentions in 10-Ks
- Net cashNo—More cash than debt, positive EBITDA
- Buyout-sizedYes$3.6B market capMarket cap $500M–$5B
Catalysts 0 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingNo−$4M netNet sales over $10M in 12 months
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Net income | $176M | $166M | $145M | $195M | $181M | 7.3% |
| Operating cash flow | $143M | $574M | $149M | $106M | $271M | 155% |
| Capex | $21M | $15M | $22M | $14M | $34M | 147% |
| Stock-based comp | $10M | $12M | $14M | $14M | $18M | 28% |
| Buybacks | $21M | $0 | $0 | $0 | $13M | |
| Dividends | $50M | $50M | $50M | $54M | $79M | 46% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $70K · 1
- Open-market sells, 12 mo
- $4M · 10
- Net
- −$4M
Pay vs performance
No pay-versus-performance disclosure yet.